The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis. [electronic resource]
- European journal of neurology Apr 2013
- 708-13 p. digital
Publication Type: Journal Article
1468-1331
10.1111/ene.12057 doi
Adult Age of Onset Aged Anti-Inflammatory Agents--therapeutic use Autoantibodies--blood Blepharoptosis--etiology Cholinesterase Inhibitors--therapeutic use Disease Progression Eye Diseases--drug therapy Female Follow-Up Studies Humans Immunosuppressive Agents--therapeutic use Male Middle Aged Muscle Weakness--etiology Myasthenia Gravis--drug therapy Oculomotor Muscles--physiopathology Prednisolone--therapeutic use Pyridostigmine Bromide--therapeutic use Receptors, Cholinergic--immunology Retrospective Studies Risk Assessment